Abstract:Highlights • A biomimetic nanoplatform was constructed for precise delivery of carbon monoxide (CO) donor to ischemia reperfusion area. • M/ could realize controlled release of CO by reacting with peroxynitrite (ONOO − ). • M/ could ameliorate myocardial ischemia-reperfusion (MI/R) injury by clearing harmful ONOO − , attenuating inflammatory response, inhibiting cardiomyocyte apoptosis, and promoting mitochondrial biogenesis. Myocardial ischemia-reperfusion (MI/R) injury is common in patients who undergo revascularization therapy for myocardial infarction, often leading to cardiac dysfunction. Carbon monoxide (CO) has emerged as a therapeutic molecule due to its beneficial properties such as anti-inflammatory, anti-apoptotic, and mitochondrial biogenesis-promoting properties. However, its clinical application is limited due to uncontrolled release, potential toxicity, and poor targeting efficiency. To address these limitations, a peroxynitrite (ONOO − )-triggered CO donor (PCOD585) is utilized to generate a poly (lactic-co-glycolic acid) (PLGA)-based, biomimetic CO nanogenerator (M/) that is coated with the macrophage membrane, which could target to the ischemic area and neutralize proinflammatory cytokines. In the ischemic area, local produced ONOO − triggers the continuous release of CO from M/, which efficiently ameliorates MI/R injury by clearing harmful ONOO − , attenuating the inflammatory response, inhibiting cardiomyocyte apoptosis, and promoting mitochondrial biogenesis. This study provides a novel insight into the safe therapeutic use of CO for MI/R injury by utilizing a novel CO donor combined with biomimetic technology. The M/ nanogenerator offers targeted delivery of CO to the ischemic area, minimizing potential toxicity and enhancing therapeutic efficacy. Graphical abstract Download : Download high-res image (445KB) Download : Download full-size image Illustrations displaying the preparation process of the macrophage cell membrane-camouflaged M/ and the mechanism of M/ to treat MI/R injury. The process is divided into 3 steps: 1) macrophage membrane coating promotes accumulation of nanoparticles () in ischemic area of heart.2) M/ is internalized by nearby cells and release PCOD585, which react with ONOO − to release CO.3) CO inhibits apoptosis, decreases pro-inflammatory macrophage, and facilitates the mitochondrial biogenesis.

Metal-Free CO Prodrugs Activated by Molecular Oxygen Protect against Doxorubicin-Induced Cardiomyopathy in Mice

Metabolomic Analysis of the Ameliorative Effect of Enhanced Proline Metabolism on Hypoxia-Induced Injury in Cardiomyocytes.

Metal-based carbon monoxide releasing molecules with promising cytotoxic properties

Beneficial Effects of Oral Carbon Monoxide on Doxorubicin-Induced Cardiotoxicity

Mitigation of doxorubicin-induced cardiotoxicity with an H2O2-Activated, H2S-Donating hybrid prodrug

Small-molecule mediated MuRF1 inhibition protects from doxorubicin-induced cardiac atrophy and contractile dysfunction

Polyprodrug Nanomedicine for Chemiexcitation-Triggered Self-Augmented Cancer Chemotherapy and Gas Therapy

An ischemic area-targeting, peroxynitrite-responsive, biomimetic carbon monoxide nanogenerator for preventing myocardial ischemia-reperfusion injury

Beneficial effects of carbon monoxide-releasing molecule-2 (CORM-2) on acute doxorubicin cardiotoxicity in mice: role of oxidative stress and apoptosis

An Unusual Application of Multifunctional Nanozyme Derived from COF: Augmenting Chemoimmunotherapy while Attenuating Cardiotoxicity

A Novel Precipitating-Fluorochrome-based Fluorescent Probe for Monitoring Carbon Monoxide During Drug-Induced Liver Injury.

Biomineralized CO gas-releasing nanoprodrug for endoplasmic reticulum stress mediated cancer therapy

COX5A Alleviates Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress, Mitochondrial Dysfunction and Cardiomyocyte Apoptosis

CoOx‐Caged Metal‐Organic Frameworks for Sonocatalyzing CO2 to Co for Ultrasound‐Assisted Chemodynamic‐Gas Cancer Therapy

X-ray-controllable release of carbon monoxide potentiates radiotherapy by ultrastable hybrid nanoreservoirs

Dual delivery of carbon monoxide and doxorubicin using haemoglobin-albumin cluster: Proof of concept for well-tolerated cancer therapy

Carbon monoxide-releasing molecule-2 ameliorates postresuscitation myocardial dysfunction in rat via mitochondrial-mediated apoptosis pathway and the regulation of mitochondrial dynamics

A Cardiac‐Targeting and Anchoring Bimetallic Cluster Nanozyme Alleviates Chemotherapy‐Induced Cardiac Ferroptosis and PANoptosis

Overexpression of COX5A protects H9c2 cells against doxorubicin-induced cardiotoxicity.

Peroxynitrite-Triggered Carbon Monoxide Donor Improves Ischemic Stroke Outcome by Inhibiting Neuronal Apoptosis and Ferroptosis

Primary Protection of Diosmin Against Doxorubicin Cardiotoxicity via Inhibiting Oxido-Inflammatory Stress and Apoptosis in Rats